Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 21, 2021 Filed May 24, 2021 21:19 UTC |
Richner RandelDirector
|
GrantOrdinary shares, par value NIS 0.25 per share | 20,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-21-001852 · zk2126086.xml · nonDerivative · entry 1 Richner Randel · CIK 0001827014 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 48,330 F1 · shares: Represents 20,833 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on November 1, 2020 under the ReWalk Amended and Restated 2014 Incentive Compensation Plan, in connection with the reporting person's appointment as director effective as of that date. The RSUs vest in four equal quarterly installments starting three months from the date of grant, and may only be settled in Ordinary Shares. Read SEC document |
| May 21, 2021 Filed May 24, 2021 21:12 UTC |
Dykan JeffDirector
|
GrantOrdinary Shares, par value NIS 0.25 per share | 20,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-21-001848 · zk2126084.xml · nonDerivative · entry 1 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 91,450 F1 · shares: Represents 20,833 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on May 24, 2021 under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest in four equal quarterly instalments starting three months following the date of grant. F2 · shares: The Reporting Person immediately and automatically assigned these Ordinary Shares when they were granted to SCP Vitalife II ("SCP") pursuant to the policies of SCP regarding Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Issuer with the permission of SCP. F3 · balance_after: Based on filings made with the SEC, consists of 40,707 ordinary shares beneficially owned by SCP Vitalife Partners II, L.P. ("SCP Vitalife Partners II"), a limited partnership organized in the Cayman Islands, 13,596 ordinary shares beneficially owned by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife Partners Israel II"), a limited partnership organized in Israel, 2,480 ordinary shares beneficially owned by Vitalife Partners (Overseas) L.P. ("Vitalife Partners Overseas"), 820 ordinary shares beneficially owned by Vitalife Partners (Israel) L.P. ("Vitalife Partners Israel"), 829 ordinary shares beneficially owned by Vitalife Partners (D.C.M) L.P. ("Vitalife Partners DCM") and 1,571 ordinary shares held by the Israel Innovation Authority (the "IIA"), that Vitalife Partners Overseas, Vitalife Partners Israel and Vitalife Partners DCM have the right to acquire from IIA. The reporting person is therefore deemed to beneficially own 60,003 shares of the Company Read SEC document |
| May 21, 2021 Filed May 24, 2021 21:10 UTC |
Dan AryehDirector
|
GrantOrdinary Shares, par value NIS 0.25 per share | 20,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-21-001846 · zk2126083.xml · nonDerivative · entry 1 Dan Aryeh · CIK 0001661255 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 37,589 F1 · shares: Represents 20,833 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on May 21, 2021 under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest in four equal quarterly instalments starting three months following the date of grant. Read SEC document |
| May 21, 2021 Filed May 25, 2021 10:02 UTC |
Jasinski Lawrence JDirector · Chief Executive Officer
|
GrantOrdinary Shares, par value NIS 0.25 per share | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-21-001862 · zk2126078.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 458,066 F1 · shares: Represents 150,000 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on May 21, 2021 under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest ratably in four equal annual installments starting on the first anniversary of the grant date. Read SEC document |
| May 21, 2021 Filed May 25, 2021 11:10 UTC Amendment |
Richner RandelDirector
|
GrantOrdinary shares, par value NIS 0.25 per share | 20,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-21-001868 · zk2126101.xml · nonDerivative · entry 1 Richner Randel · CIK 0001827014 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 48,330 F1 · shares: Represents 20,833 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on May 21, 2021 under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest in four equal quarterly instalments starting three months following the date of grant. Read SEC document |
| May 21, 2021 Filed May 25, 2021 11:05 UTC Amendment |
Dykan JeffDirector
|
GrantOrdinary Shares, par value NIS 0.25 per share | 20,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-21-001866 · zk2126100.xml · nonDerivative · entry 1 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 91,450 F1 · shares: Represents 20,833 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on May 21, 2021 under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest in four equal quarterly instalments starting three months following the date of grant. F2 · shares: The Reporting Person immediately and automatically assigned these Ordinary Shares when they were granted to SCP Vitalife II ("SCP") pursuant to the policies of SCP regarding Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Issuer with the permission of SCP. F3 · balance_after: Based on filings made with the SEC, consists of 40,707 ordinary shares beneficially owned by SCP Vitalife Partners II, L.P. ("SCP Vitalife Partners II"), a limited partnership organized in the Cayman Islands, 13,596 ordinary shares beneficially owned by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife Partners Israel II"), a limited partnership organized in Israel, 2,480 ordinary shares beneficially owned by Vitalife Partners (Overseas) L.P. ("Vitalife Partners Overseas"), 820 ordinary shares beneficially owned by Vitalife Partners (Israel) L.P. ("Vitalife Partners Israel"), 829 ordinary shares beneficially owned by Vitalife Partners (D.C.M) L.P. ("Vitalife Partners DCM") and 1,571 ordinary shares held by the Israel Innovation Authority (the "IIA"), that Vitalife Partners Overseas, Vitalife Partners Israel and Vitalife Partners DCM have the right to acquire from IIA. The reporting person is therefore deemed to beneficially own 60,003 shares of the Company Read SEC document |
| May 21, 2021 Filed May 27, 2021 17:18 UTC Amendment |
Weisman WayneDirector
|
GrantOrdinary Shares, par value NIS 0.25 per share | 13,888 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-21-001947 · zk2126123.xml · nonDerivative · entry 1 Weisman Wayne · CIK 0001602327 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 90,648 F1 · shares: The Reporting Person is amending the Form 4 filed on May 24, 2021, which, due to an administrative error, inadvertently reported the grant on May 21, 2021 of 20,833 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The Reporting Person was actually granted 13,888 Ordinary Shares, issuable upon the vesting of RSUs. The RSUs vest in four equal quarterly instalments starting three months following the date of grant. F2 · shares: The Reporting Person immediately and automatically assigned these Ordinary Shares to SCP Vitalife II ("SCP") pursuant to the policies of SCP regarding Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Issuer with the permission of SCP. F3 · balance_after: Based on filings made with the SEC, consists of 40,707 ordinary shares beneficially owned by SCP Vitalife Partners II, L.P. ("SCP Vitalife Partners II"), a limited partnership organized in the Cayman Islands, 13,596 ordinary shares beneficially owned by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife Partners Israel II"), a limited partnership organized in Israel, 2,480 ordinary shares beneficially owned by Vitalife Partners (Overseas) L.P. ("Vitalife Partners Overseas"), 820 ordinary shares beneficially owned by Vitalife Partners (Israel) L.P. ("Vitalife Partners Israel"), 829 ordinary shares beneficially owned by Vitalife Partners (D.C.M) L.P. ("Vitalife Partners DCM") and 1,571 ordinary shares held by the Israel Innovation Authority (the "IIA"), that Vitalife Partners Overseas, Vitalife Partners Israel and Vitalife Partners DCM have the right to acquire from IIA. The reporting person is therefore deemed to beneficially own 60,003 shares of the Company Read SEC document |
| May 21, 2021 Filed May 27, 2021 17:12 UTC Amendment |
PODUSKA JOHN WILLIAM SRDirector
|
GrantOrdinary Shares, par value NIS 0.25 per share | 13,888 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-21-001943 · zk2126121.xml · nonDerivative · entry 1 PODUSKA JOHN WILLIAM SR · CIK 0001190078 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 30,645 F1 · shares: The Reporting Person is amending the Form 4 filed on May 24, 2021, which, due to an administrative error, inadvertently reported the grant on May 21, 2021 of 20,833 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The Reporting Person was actually granted 13,888 Ordinary Shares, issuable upon the vesting of RSUs. The RSUs vest in four equal quarterly instalments starting three months following the date of grant. Read SEC document |
| May 21, 2021 Filed May 27, 2021 21:16 UTC Amendment |
Richner RandelDirector
|
GrantOrdinary shares, par value NIS 0.25 per share | 13,888 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-21-001945 · zk2126122.xml · nonDerivative · entry 1 Richner Randel · CIK 0001827014 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 41,385 F1 · shares: The Reporting Person is amending the Form 4 filed on May 24, 2021, as amended on May 25, 2021, which, due to an administrative error, inadvertently reported the grant on May 21, 2021 of 20,833 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The Reporting Person was actually granted 13,888 Ordinary Shares, issuable upon the vesting of RSUs. The RSUs vest in four equal quarterly instalments starting three months following the date of grant. Read SEC document |
| May 21, 2021 Filed May 27, 2021 21:09 UTC Amendment |
Ichiki YasushiDirector
|
GrantOrdinary Shares, par value NIS 0.25 per share | 13,888 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-21-001941 · zk2126120.xml · nonDerivative · entry 1 Ichiki Yasushi · CIK 0001661271 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 30,645 F1 · shares: The Reporting Person is amending the Form 4 filed on May 24, 2021, which, due to an administrative error, inadvertently reported the grant on May 21, 2021 of 20,833 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The Reporting Person was actually granted 13,888 Ordinary Shares, issuable upon the vesting of RSUs. The RSUs vest in four equal quarterly instalments starting three months following the date of grant. Read SEC document |
| May 21, 2021 Filed May 27, 2021 21:07 UTC Amendment |
Engelhardt YohananDirector
|
GrantOrdinary Shares, par value NIS 0.25 per share | 13,888 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-21-001939 · zk2126119.xml · nonDerivative · entry 1 Engelhardt Yohanan · CIK 0001739934 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 30,585 F1 · shares: The Reporting Person is amending the Form 4 filed on May 24, 2021, which, due to an administrative error, inadvertently reported the grant on May 21, 2021 of 20,833 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The Reporting Person was actually granted 13,888 Ordinary Shares, issuable upon the vesting of RSUs. The RSUs vest in four equal quarterly instalments starting three months following the date of grant. Read SEC document |
| May 21, 2021 Filed May 27, 2021 21:03 UTC Amendment |
Dykan JeffDirector
|
GrantOrdinary Shares, par value NIS 0.25 per share | 13,888 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-21-001937 · zk2126118.xml · nonDerivative · entry 1 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 84,505 F1 · shares: The Reporting Person is amending the Form 4 filed on May 24, 2021, as amended on May 25, 2021, which, due to an administrative error, inadvertently reported the grant on May 21, 2021 of 20,833 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The Reporting Person was actually granted 13,888 Ordinary Shares, issuable upon the vesting of RSUs. The RSUs vest in four equal quarterly instalments starting three months following the date of grant. F2 · shares: The Reporting Person immediately and automatically assigned these Ordinary Shares when they were granted to SCP Vitalife II ("SCP") pursuant to the policies of SCP regarding Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Issuer with the permission of SCP. F3 · balance_after: Based on filings made with the SEC, consists of 40,707 ordinary shares beneficially owned by SCP Vitalife Partners II, L.P. ("SCP Vitalife Partners II"), a limited partnership organized in the Cayman Islands, 13,596 ordinary shares beneficially owned by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife Partners Israel II"), a limited partnership organized in Israel, 2,480 ordinary shares beneficially owned by Vitalife Partners (Overseas) L.P. ("Vitalife Partners Overseas"), 820 ordinary shares beneficially owned by Vitalife Partners (Israel) L.P. ("Vitalife Partners Israel"), 829 ordinary shares beneficially owned by Vitalife Partners (D.C.M) L.P. ("Vitalife Partners DCM") and 1,571 ordinary shares held by the Israel Innovation Authority (the "IIA"), that Vitalife Partners Overseas, Vitalife Partners Israel and Vitalife Partners DCM have the right to acquire from IIA. The reporting person is therefore deemed to beneficially own 60,003 shares of the Company Read SEC document |
| May 21, 2021 Filed May 27, 2021 21:01 UTC Amendment |
Dan AryehDirector
|
GrantOrdinary Shares, par value NIS 0.25 per share | 13,888 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-21-001935 · zk2126117.xml · nonDerivative · entry 1 Dan Aryeh · CIK 0001661255 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 30,644 F1 · shares: The Reporting Person is amending the Form 4 filed on May 24, 2021, which, due to administrative error, inadvertently reported the grant on May 21, 2021 of 20,833 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The Reporting Person was actually granted 13,888 Ordinary Shares, issuable upon the vesting of RSUs. The RSUs vest in four equal quarterly instalments starting three months following the date of grant. Read SEC document |
| May 04, 2021 Filed May 5, 2021 20:46 UTC |
Jasinski Lawrence JDirector · Chief Executive Officer
|
SaleOrdinary Shares, par value NIS 0.25 per share | 148 | $1.90 | $281.20 |
DisclosureSEC source: 0001178913-21-001613 · zk2125986.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 308,066 F1 · shares: Represents Ordinary Shares sold in the open market on May 4, 2021, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting, on May 3, 2021, of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between Mr. Jasinski and the Company. F2 · price: Sale price per share of the Company's Ordinary Shares on the transaction date. Read SEC document |
| April 05, 2021 Filed Apr 5, 2021 20:30 UTC |
Dykan JeffDirector
|
Tax withholdingOrdinary Shares, par value NIS 0.25 per share | 835 | $2.44 | $2,037.40 |
DisclosureSEC source: 0001178913-21-001288 · zk2125852.xml · nonDerivative · entry 1 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 70,617 F1 · shares: Represents Ordinary Shares sold in the open market on April 05, 2021, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. F2 · shares: The Reporting Person immediately and automatically assigned these Ordinary Shares when they were granted to SCP Vitalife II ("SCP") pursuant to the policies of SCP regarding Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Issuer with the permission of SCP. F3 · price: Market price per share of the Company's Ordinary Shares on the transaction date. Read SEC document |
| March 29, 2021 Filed Mar 29, 2021 20:00 UTC |
Jasinski Lawrence JDirector · Chief Executive Officer
|
Tax withholdingOrdinary Shares, par value NIS 0.25 per share | 202 | $2.38 | $480.76 |
DisclosureSEC source: 0001178913-21-001214 · zk2125825.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 308,214 F1 · shares: Represents Ordinary Shares sold in the open market on March 29, 2021, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting, on March 27, 2021, of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. F2 · price: Market price per share of the Company's Ordinary Shares on the transaction date. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 12:12 UTC |
Dykan JeffDirector
|
Tax withholdingOrdinary Shares, par value NIS 0.25 per share | 840 | $1.36 | $1,142.40 |
DisclosureSEC source: 0001178913-21-000029 · zk2125326.xml · nonDerivative · entry 1 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 71,452 F1 · shares: Represents Ordinary Shares sold in the open market on January 4, 2021, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. F2 · shares: The Reporting Person immediately and automatically assigned these Ordinary Shares to SCP Vitalife II ("SCP") pursuant to the policies of SCP regarding Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Issuer with the permission of SCP. F3 · price: Market price per share of the Company's Ordinary Shares on the transaction date. Read SEC document |
| November 01, 2020 Filed Nov 4, 2020 21:35 UTC |
Richner RandelDirector
|
GrantOrdinary shares, par value NIS 0.25 per share | 27,497 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-20-003007 · ownership.xml · nonDerivative · entry 1 Richner Randel · CIK 0001827014 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 27,497 F1 · shares: Represents 27,497 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on November 1, 2020 under the ReWalk Amended and Restated 2014 Incentive Compensation Plan, in connection with the reporting person's appointment as director effective as of that date. The RSUs vest in four equal quarterly installments starting three months from the date of grant, and may only be settled in Ordinary Shares. Read SEC document |
| October 06, 2020 Filed Oct 6, 2020 20:30 UTC |
Jasinski Lawrence JDirector · Chief Executive Officer
|
Tax withholdingOrdinary Shares, par value NIS 0.25 per share | 348 | $1.06 | $368.88 |
DisclosureSEC source: 0001178913-20-002778 · zk2024970.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 308,416 F1 · shares: Represents Ordinary Shares sold in the open market on October 6, 2020, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting, on October 5, 2020, of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. F2 · price: Market price per share of the Company's Ordinary Shares on the transaction date. Read SEC document |
| October 05, 2020 Filed Oct 5, 2020 20:05 UTC |
Dykan JeffDirector
|
Tax withholdingOrdinary Shares, par value NIS 0.25 per share | 840 | $1.08 | $907.20 |
DisclosureSEC source: 0001178913-20-002768 · zk2024966.xml · nonDerivative · entry 1 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 72,292 F1 · shares: Represents Ordinary Shares sold in the open market on October 4, 2020, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. F2 · shares: The Reporting Person immediately and automatically assigned these Ordinary Shares to SCP Vitalife II ("SCP") pursuant to the policies of SCP regarding Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Issuer with the permission of SCP. F3 · balance_after: Market price per share of the Company's Ordinary Shares on the transaction date. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 17:15 UTC |
Weisman WayneDirector
|
GrantOrdinary Shares, par value NIS 0.25 per share | 10,948 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-20-001995 · zk2024594.xml · nonDerivative · entry 1 Weisman Wayne · CIK 0001602327 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 76,760 F1 · shares: Represents 10,948 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on July 2, 2020 under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest in four equal quarterly installments starting three months following the date of grant. F2 · shares: The Reporting Person immediately and automatically assigned these Ordinary Shares to SCP Vitalife II ("SCP") pursuant to the policies of SCP regarding Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Issuer with the permission of SCP. F3 · balance_after: Reflects our one-for-twenty-five reverse share split that became effective on April 1, 2019 F4 · balance_after: Based on filings made with the SEC, consists of 40,707 ordinary shares beneficially owned by SCP Vitalife Partners II, L.P. ("SCP Vitalife Partners II"), a limited partnership organized in the Cayman Islands, 13,596 ordinary shares beneficially owned by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife Partners Israel II"), a limited partnership organized in Israel, 2,480 ordinary shares beneficially owned by Vitalife Partners (Overseas) L.P. ("Vitalife Partners Overseas"), 820 ordinary shares beneficially owned by Vitalife Partners (Israel) L.P. ("Vitalife Partners Israel"), 829 ordinary shares beneficially owned by Vitalife Partners (D.C.M) L.P. ("Vitalife Partners DCM") and 1,571 ordinary shares held by the Israel Innovation Authority (the "IIA"), that Vitalife Partners Overseas, Vitalife Partners Israel and Vitalife Partners DCM have the right to acquire from IIA. The reporting person is therefore deemed to beneficially own 60,003 shares of the Company Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 17:11 UTC |
PODUSKA JOHN WILLIAM SRDirector
|
GrantOrdinary Shares, par value NIS 0.25 per share | 10,948 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-20-001993 · zk2024593.xml · nonDerivative · entry 1 PODUSKA JOHN WILLIAM SR · CIK 0001190078 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 16,757 F1 · shares: Represents 9,036 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on July 2, 2020 under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest in four equal quarterly installments starting three months following the date of grant. F2 · balance_after: Reflects our one-for-twenty-five reverse share split that became effective on April 1, 2019. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 21:27 UTC |
Ichiki YasushiDirector
|
GrantOrdinary Shares, par value NIS 0.25 per share | 10,948 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-20-001998 · zk2024595.xml · nonDerivative · entry 1 Ichiki Yasushi · CIK 0001661271 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 16,757 F1 · shares: Represents 10,948 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on July 2, 2020 under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest in four equal quarterly instalments starting three months following the date of grant. F2 · balance_after: Reflects our one-for-twenty-five reverse share split that became effective on April 1, 2019 Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 21:09 UTC |
Dykan JeffDirector
|
GrantOrdinary Shares, par value NIS 0.25 per share | 10,948 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-20-001989 · zk2024591.xml · nonDerivative · entry 1 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 73,132 F1 · shares: Represents 10,948 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on July 2, 2020 under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest in four equal quarterly instalments starting three months following the date of grant. F2 · shares: The Reporting Person immediately and automatically assigned these Ordinary Shares to SCP Vitalife II ("SCP") pursuant to the policies of SCP regarding Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Issuer with the permission of SCP. F3 · balance_after: Based on filings made with the SEC, consists of 40,707 ordinary shares beneficially owned by SCP Vitalife Partners II, L.P. ("SCP Vitalife Partners II"), a limited partnership organized in the Cayman Islands, 13,596 ordinary shares beneficially owned by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife Partners Israel II"), a limited partnership organized in Israel, 2,480 ordinary shares beneficially owned by Vitalife Partners (Overseas) L.P. ("Vitalife Partners Overseas"), 820 ordinary shares beneficially owned by Vitalife Partners (Israel) L.P. ("Vitalife Partners Israel"), 829 ordinary shares beneficially owned by Vitalife Partners (D.C.M) L.P. ("Vitalife Partners DCM") and 1,571 ordinary shares held by the Israel Innovation Authority (the "IIA"), that Vitalife Partners Overseas, Vitalife Partners Israel and Vitalife Partners DCM have the right to acquire from IIA. The reporting person is therefore deemed to beneficially own 60,003 shares of the Company F3 · ownership.nature: Based on filings made with the SEC, consists of 40,707 ordinary shares beneficially owned by SCP Vitalife Partners II, L.P. ("SCP Vitalife Partners II"), a limited partnership organized in the Cayman Islands, 13,596 ordinary shares beneficially owned by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife Partners Israel II"), a limited partnership organized in Israel, 2,480 ordinary shares beneficially owned by Vitalife Partners (Overseas) L.P. ("Vitalife Partners Overseas"), 820 ordinary shares beneficially owned by Vitalife Partners (Israel) L.P. ("Vitalife Partners Israel"), 829 ordinary shares beneficially owned by Vitalife Partners (D.C.M) L.P. ("Vitalife Partners DCM") and 1,571 ordinary shares held by the Israel Innovation Authority (the "IIA"), that Vitalife Partners Overseas, Vitalife Partners Israel and Vitalife Partners DCM have the right to acquire from IIA. The reporting person is therefore deemed to beneficially own 60,003 shares of the Company Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 21:29 UTC |
Engelhardt YohananDirector
|
GrantOrdinary Shares, par value NIS 0.25 per share | 10,948 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-20-002000 · zk2024596.xml · nonDerivative · entry 1 Engelhardt Yohanan · CIK 0001739934 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 16,697 F1 · shares: Represents 10,948 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on July 2, 2020 under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest in four equal quarterly instalments starting three months following the date of grant. F2 · balance_after: Reflects our one-for-twenty-five reverse share split that became effective on April 1, 2019. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 21:07 UTC |
Dan AryehDirector
|
GrantOrdinary Shares, par value NIS 0.25 per share | 10,948 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-20-001987 · zk2024590.xml · nonDerivative · entry 1 Dan Aryeh · CIK 0001661255 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 16,756 F1 · shares: Represents 10,948 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on July 2, 2020 under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest in four equal quarterly instalments starting three months following the date of grant. F2 · balance_after: Reflects our one-for-twenty-five reverse share split that became effective on April 1, 2019. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 20:57 UTC |
Gon OriChief Financial Officer
|
GrantOrdinary Shares, par value NIS 0.25 per share | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-20-001985 · zk2024651.xml · nonDerivative · entry 2 Gon Ori · CIK 0001732525 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 16,282 F2 · shares: Represents 10,000 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on July 2, 2020 under the ReWalk 2014 Equity Incentive Plan. The RSUs vest immediately on the date of grant. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 20:57 UTC |
Gon OriChief Financial Officer
|
GrantOrdinary Shares, par value NIS 0.25 per share | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-20-001985 · zk2024651.xml · nonDerivative · entry 1 Gon Ori · CIK 0001732525 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 166,282 F1 · shares: Represents 150,000 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on July 2, 2020 under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in four equal yearly instalments starting on the first anniversary of the date of grant. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 20:56 UTC |
Koren OfirSnr VP, R&D and Regulatory
|
GrantOrdinary Shares, par value NIS 0.25 per share | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-20-001983 · zk2024650.xml · nonDerivative · entry 1 Koren Ofir · CIK 0001661277 · Snr VP, R&D and Regulatory 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 64,995 F1 · shares: Represents 60,000 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on July 2, 2020 under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in four equal yearly instalments starting on the first anniversary of the date of grant. Read SEC document |
| June 29, 2020 Filed Jun 30, 2020 10:02 UTC |
Jasinski Lawrence JDirector · Chief Executive Officer
|
Tax withholdingOrdinary Shares, par value NIS 0.25 per share | 194 | $1.77 | $343.38 |
DisclosureSEC source: 0001178913-20-001894 · zk2024615.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 308,764 F1 · shares: Represents Ordinary Shares sold in the open market on June 29, 2020, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting, on June 27, 2020, of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. F2 · price: Closing market price per share of the Company's Ordinary Shares on the transaction date. Read SEC document |
| June 18, 2020 Filed Jun 23, 2020 21:00 UTC |
Jasinski Lawrence JDirector · Chief Executive Officer
|
GrantOrdinary Shares, par value NIS 0.25 per share | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-20-001855 · zk2024592.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 308,958 F1 · shares: Represents 300,000 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on June 18, 2020 under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest in four equal quarterly instalments starting three months following the date of grant. Read SEC document |
| June 18, 2020 Filed Mar 16, 2021 10:03 UTC Amendment |
Jasinski Lawrence JDirector · Chief Executive Officer
|
GrantOrdinary Shares, par value NIS 0.25 per share | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-21-001045 · zk2125759.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 308,958 F1 · shares: Represents 300,000 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on June 18, 2020 under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest ratably in four equal annual installments starting on the first anniversary of the grant date. Read SEC document |
| March 30, 2020 Filed Apr 21, 2020 10:02 UTC |
Dykan JeffDirector
|
Tax withholdingOrdinary Shares, par value NIS 0.01 per share | 375 | $0.47 | $176.25 |
DisclosureSEC source: 0001178913-20-001149 · zk2024281.xml · nonDerivative · entry 1 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 2,181 F1 · shares: Represents Ordinary Shares sold in the open market on March 30, 2020, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. F2 · shares: The Reporting Person immediately and automatically assigned these Ordinary Shares to SCP Vitalife II ("SCP") pursuant to the policies of SCP regarding Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Issuer with the permission of SCP. F3 · price: Closing market price per share of the Company's Ordinary Shares on the transaction date. Read SEC document |
| January 02, 2020 Filed Jan 7, 2020 20:32 UTC |
Dykan JeffDirector
|
Tax withholdingOrdinary Shares, par value NIS 0.01 per share | 3,252 | $2.16 | $7,024.32 |
DisclosureSEC source: 0001213900-20-000360 · doc4.xml · nonDerivative · entry 1 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 2,556 F1 · shares: Represents Ordinary Shares sold in the open market on January 02, 2020, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. F2 · shares: The Reporting Person immediately and automatically assigned these Ordinary Shares to SCP Vitalife II ("SCP") pursuant to the policies of SCP regarding Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Issuer with the permission of SCP. F3 · price: Closing market price per share of the Company's Ordinary Shares on the transaction date. Read SEC document |
| October 05, 2019 Filed Oct 8, 2019 19:57 UTC |
Jasinski Lawrence JDirector · Chief Executive Officer
|
Tax withholdingOrdinary Shares, par value NIS 0.01 per share | 469 | $2.86 | $1,341.34 |
DisclosureSEC source: 0001213900-19-019973 · doc4.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: Not disclosed F1 · shares: Represents Ordinary Shares sold in the open market on June 27, 2019, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting, on October 5, 2019, of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in three equal annual installments starting on the first anniversary of the date of grant, and may only be settled in Ordinary Shares. F2 · price: Closing market price per share of the Company's Ordinary Shares on the transaction date F3 · valueOwnedAfter: Reflects our one-for-twenty-five reverse share split that became effective on April 1, 2019 Read SEC document |
| June 27, 2019 Filed Jul 1, 2019 12:32 UTC |
Jasinski Lawrence JDirector · Chief Executive Officer
|
Tax withholdingOrdinary Shares, par value NIS 0.01 per share | 105 | $4.27 | $448.36 |
DisclosureSEC source: 0001213900-19-011824 · doc4.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 9,427 F1 · shares: Represents Ordinary Shares sold in the open market on June 27, 2019, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting, on June 27, 2019, of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. One-fourth of these RSUs vested on June 27, 2018, the first anniversary of the date of grant, with the remaining RSUs vesting in three equal annual installments thereafter. F2 · price: Closing market price per share of the Company's Ordinary Shares on the transaction date. F3 · balance_after: Reflects our one-for-twenty-five reverse share split that became effective on April 1, 2019 Read SEC document |
| June 07, 2019 Filed Jun 10, 2019 20:09 UTC |
Koren OfirSnr VP, R&D and Regulatory
|
SaleOrdinary Shares, par value NIS 0.25 per share | 150 | $6.51 | $976.50 |
DisclosureSEC source: 0001213900-19-010421 · doc4.xml · nonDerivative · entry 3 Koren Ofir · CIK 0001661277 · Snr VP, R&D and Regulatory 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,995 Read SEC document |
| June 07, 2019 Filed Jun 10, 2019 20:09 UTC |
Koren OfirSnr VP, R&D and Regulatory
|
SaleOrdinary Shares, par value NIS 0.25 per share | 108 | $6.52 | $704.16 |
DisclosureSEC source: 0001213900-19-010421 · doc4.xml · nonDerivative · entry 2 Koren Ofir · CIK 0001661277 · Snr VP, R&D and Regulatory 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,145 Read SEC document |
| June 07, 2019 Filed Jun 10, 2019 20:09 UTC |
Koren OfirSnr VP, R&D and Regulatory
|
SaleOrdinary Shares, par value NIS 0.25 per share | 100 | $6.50 | $650.00 |
DisclosureSEC source: 0001213900-19-010421 · doc4.xml · nonDerivative · entry 1 Koren Ofir · CIK 0001661277 · Snr VP, R&D and Regulatory 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,253 Read SEC document |
| June 01, 2019 Filed Jun 6, 2019 20:02 UTC |
Gon OriChief Financial Officer
|
GrantOrdinary Shares, par value NIS 0.01 per share | 4,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-19-010197 · doc4.xml · nonDerivative · entry 1 Gon Ori · CIK 0001732525 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 6,282 F1 · shares: Represents 4,500 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on June 1, 2019 under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in three equal yearly installments starting on the first anniversary of the date of grant. Read SEC document |
| June 01, 2019 Filed Jun 6, 2019 20:01 UTC |
Koren OfirSnr VP, R&D and Regulatory
|
GrantOrdinary Shares, par value NIS 0.01 per share | 3,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-19-010194 · doc4.xml · nonDerivative · entry 1 Koren Ofir · CIK 0001661277 · Snr VP, R&D and Regulatory 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 5,353 F1 · shares: (1) Represents 3,750 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on June 1, 2019 under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in three equal yearly installments starting on the first anniversary of the date of grant. Read SEC document |
| May 24, 2019 Filed May 28, 2019 19:59 UTC |
Jasinski Lawrence JDirector · Chief Executive Officer
|
Tax withholdingOrdinary Shares, par value NIS 0.01 per share | 23 | $3.03 | $69.69 |
DisclosureSEC source: 0001213900-19-009646 · doc4.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 9,532 F1 · shares: Represents Ordinary Shares withheld by ReWalk Robotics Ltd. (the "Company") at the Reporting Person's request, as permitted under the ReWalk 2014 Equity Incentive Plan, to satisfy the Reporting Person's tax withholding obligation in connection with the vesting on Friday, May 24, 2019 of restricted stock units previously awarded to the Reporting Person. There was no open market sale of Ordinary Shares by the Reporting Person. F2 · price: Closing market price per share of the Company's Ordinary Shares on the transaction date. F3 · balance_after: Reflects our one-for-twenty-five reverse share split that became effective on April 1, 2019 Read SEC document |
| May 15, 2019 Filed May 23, 2019 20:03 UTC |
Han ChunlinDirector
|
GrantOrdinary shares, par value NIS 0.25 per share | 11,029 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-19-009494 · ownership.xml · nonDerivative · entry 1 Han Chunlin · CIK 0001777218 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 11,029 F1 · balance_after: Represents 11,029 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on May 15, 2019 under the ReWalk 2014 Incentive Compensation Plan, in connection with the reporting person's appointment as director effective as of that date. The RSUs vest in four equal quarterly installments starting three months from the date of grant, and may only be settled in Ordinary Shares. Read SEC document |
| May 03, 2019 Filed May 7, 2019 20:02 UTC |
Jasinski Lawrence JDirector · Chief Executive Officer
|
Tax withholdingOrdinary Shares, par value NIS 0.01 per share | 177 | $3.66 | $647.82 |
DisclosureSEC source: 0001213900-19-007964 · doc4.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 9,555 F1 · shares: Represents Ordinary Shares withheld by ReWalk Robotics Ltd. (the "Company") at the Reporting Person's request, as permitted under the ReWalk 2014 Equity Incentive Plan, to satisfy the Reporting Person's tax withholding obligation in connection with the vesting on Friday, May 3, 2019 of restricted stock units previously awarded to the Reporting Person. There was no open market sale of Ordinary Shares by the Reporting Person. F2 · price: Closing market price per share of the Company's Ordinary Shares on the transaction date. F3 · balance_after: Reflects our one-for-twenty-five reverse share split that became effective on April 1, 2019 Read SEC document |
| March 27, 2019 Filed Mar 28, 2019 07:12 UTC |
Cong NingDirector
|
GrantOrdinary Shares, par value NIS 0.01 per share | 116,496 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-19-005031 · doc4.xml · nonDerivative · entry 1 Cong Ning · CIK 0001740018 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 144,403 F1 · shares: Represents 116,496 ordinary shares, par value NIS 0.01 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on March 27, 2019 under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in four equal quarterly instalments starting three months following the date of grant. F2 · balance_after: Pursuant to the terms of the ReWalk 2014 Incentive Compensation Plan permitting the board of directors of ReWalk Robotics Ltd. (the ?Company?) to adjust the number of shares underlying equity awards in connection with stock splits, reverse stock splits or similar corporate events, the number of Ordinary Shares underlying the RSUs is subject to adjustment in connection with the Company?s planned reverse stock split, which the Company intends to effect shortly following its receipt of shareholder approval for such split on March 27, 2019. Read SEC document |
| March 27, 2019 Filed Mar 28, 2019 06:27 UTC |
Wehrly PeterDirector
|
GrantOrdinary Shares, par value NIS 0.01 per share | 116,496 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-19-005008 · doc4.xml · nonDerivative · entry 1 Wehrly Peter · CIK 0001671826 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 139,223 F1 · shares: Represents 116,496 ordinary shares, par value NIS 0.01 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on March 27, 2019 under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in four equal quarterly installments starting three months following the date of grant. F2 · balance_after: Pursuant to the terms of the ReWalk 2014 Incentive Compensation Plan permitting the board of directors of ReWalk Robotics Ltd. (the ?Company?) to adjust the number of shares underlying equity awards in connection with stock splits, reverse stock splits or similar corporate events, the number of Ordinary Shares underlying the RSUs is subject to adjustment in connection with the Company?s planned reverse stock split, which the Company intends to effect shortly following its receipt of shareholder approval for such split on March 27, 2019. Read SEC document |
| March 27, 2019 Filed Mar 28, 2019 07:17 UTC |
Weisman WayneDirector
|
GrantOrdinary Shares, par value NIS 0.01 per share | 116,496 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-19-005036 · doc4.xml · nonDerivative · entry 1 Weisman Wayne · CIK 0001602327 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 145,245 F1 · shares: Represents 116,496 ordinary shares, par value NIS 0.01 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on March 27, 2019 under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in four equal quarterly installments starting three months following the date of grant. F2 · shares: The Reporting Person immediately and automatically assigned these Ordinary Shares to SCP Vitalife II ("SCP") pursuant to the policies of SCP regarding Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Issuer with the permission of SCP. F3 · balance_after: Pursuant to the terms of the ReWalk 2014 Incentive Compensation Plan permitting the board of directors of ReWalk Robotics Ltd. (the ?Company?) to adjust the number of shares underlying equity awards in connection with stock splits, reverse stock splits or similar corporate events, the number of Ordinary Shares underlying the RSUs is subject to adjustment in connection with the Company?s planned reverse stock split, which the Company intends to effect shortly following its receipt of shareholder approval for such split on March 27, 2019. Read SEC document |
| March 27, 2019 Filed Mar 28, 2019 07:19 UTC |
PODUSKA JOHN WILLIAM SRDirector
|
GrantOrdinary Shares, par value NIS 0.01 per share | 116,496 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-19-005037 · doc4.xml · nonDerivative · entry 1 PODUSKA JOHN WILLIAM SR · CIK 0001190078 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 145,245 F1 · shares: Represents 116,496 ordinary shares, par value NIS 0.01 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on March 27, 2019 under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in four equal quarterly installments starting three months following the date of grant. F2 · balance_after: Pursuant to the terms of the ReWalk 2014 Incentive Compensation Plan permitting the board of directors of ReWalk Robotics Ltd. (the ?Company?) to adjust the number of shares underlying equity awards in connection with stock splits, reverse stock splits or similar corporate events, the number of Ordinary Shares underlying the RSUs is subject to adjustment in connection with the Company?s planned reverse stock split, which the Company intends to effect shortly following its receipt of shareholder approval for such split on March 27, 2019. Read SEC document |
| March 27, 2019 Filed Mar 28, 2019 10:42 UTC |
Jasinski Lawrence JDirector · Chief Executive Officer
|
GrantOption (Right to buy) · Derivative | 310,625 | $0.00 Strike: $0.22 | $0.00 |
DisclosureSEC source: 0001213900-19-005013 · doc4.xml · derivative · entry 2 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 529,375 Underlying: Ordinary Shares, par value NIS 0.01 per share · 310,625 shares Expires 2029-03-27 F2 · derivative.exercise_date: Represents stock options granted under the 2014 Plan on March 27, 2019. One-fourth of the options become vested and exercisable on the first anniversary of the date of the grant, with the remaining options vesting in twelve equal quarterly installments thereafter. F3 · balance_after: Pursuant to the terms of the ReWalk 2014 Incentive Compensation Plan permitting the board of directors of ReWalk Robotics Ltd. (the ?Company?) to adjust the number of shares underlying equity awards in connection with stock splits, reverse stock splits or similar corporate events, the number of Ordinary Shares underlying the RSUs is subject to adjustment in connection with the Company?s planned reverse stock split, which the Company intends to effect shortly following its receipt of shareholder approval for such split on March 27, 2019. Read SEC document |
| March 27, 2019 Filed Mar 28, 2019 10:42 UTC |
Jasinski Lawrence JDirector · Chief Executive Officer
|
GrantOrdinary Shares, par value NIS 0.01 per share | 62,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-19-005013 · doc4.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 243,315 F1 · shares: Represents 62,125 ordinary shares, par value NIS 0.01 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on March 27, 2019 under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in four equal yearly installments starting on the first anniversary of the date of grant. F3 · balance_after: Pursuant to the terms of the ReWalk 2014 Incentive Compensation Plan permitting the board of directors of ReWalk Robotics Ltd. (the ?Company?) to adjust the number of shares underlying equity awards in connection with stock splits, reverse stock splits or similar corporate events, the number of Ordinary Shares underlying the RSUs is subject to adjustment in connection with the Company?s planned reverse stock split, which the Company intends to effect shortly following its receipt of shareholder approval for such split on March 27, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.